PL
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Investigating neuroanatomical correlates of neuropathic pain in multiple sclerosis : A pilot comparative study using advanced MRI techniques | Revue neurologique | 2025 | 34 | 1 | |||
| Inflammatory predictors of Post-COVID fatigue | Brain, behavior, & immunity. Health | 2025 | 10 | 20 | |||
| Systemic cytokines related to memory function 6-9 months and 12-15 months after SARS-CoV-2 infection | Scientific reports | 2024 | 65 | 185 | |||
| High-dose glucocorticoids in COVID-19 patients with acute encephalopathy: clinical and imaging findings in a retrospective cohort study | Journal of neural transmission | 2024 | 112 | 115 | |||
| Persistence and emergence of new neuropsychological deficits following SARS-CoV-2 infection : A follow-up assessment of the Geneva COVID-COG cohort | Journal of global health | 2024 | 127 | 151 | |||
| Frequency of Abnormally Low Neuropsychological Scores in Post-COVID-19 Syndrome: the Geneva COVID-COG Cohort | Archives of clinical neuropsychology | 2023 | 498 | 445 | |||
| Brain functional connectivity alterations associated with neuropsychological performance 6–9 months following SARS‐CoV ‐2 infection | Human brain mapping | 2023 | 281 | 185 | |||
| Acute TNFα levels predict cognitive impairment 6-9 months after COVID-19 infection | Psychoneuroendocrinology | 2023 | 207 | 164 | |||
| Personality as a Predictor of Disability in Multiple Sclerosis | Archives of clinical neuropsychology | 2023 | 247 | 245 | |||
| Markers of limbic system damage following SARS-CoV-2 infection | Brain communications | 2023 | 272 | 119 | |||
| Utilité clinique des genome boards pour les maladies génétiques complexes | Revue médicale suisse | 2023 | 195 | 168 | |||
| Paroxysmal painful tonic spasms in neuromyelitis optica spectrum disorder | eNeurologicalSci | 2023 | 63 | 129 | |||
| Obstructive sleep apnea: a major risk factor for COVID-19 encephalopathy? | BMC neurology | 2023 | 88 | 137 | |||
| Multicentric evaluation of a specific intrathecal anti-Treponema pallidum IgG index as a diagnostic biomarker of neurosyphilis: results from a retro-prospective case–control study | Sexually transmitted infections | 2023 | 175 | 0 | |||
| Serum glial fibrillary acidic protein compared with neurofilament light chain as a biomarker for disease progression in multiple sclerosis | JAMA neurology | 2023 | 134 | 0 | |||
| c-Met+ Cytotoxic T Lymphocytes Exhibit Enhanced Cytotoxicity in Mice and Humans In Vitro Tumor Models | Biomedicines | 2023 | 59 | 217 | |||
| Paraneoplastic Autoimmune Limbic Encephalitis Associated with an Atypical Carcinoid Tumor of the Lung : A Case Report | Case reports in neurology | 2023 | 121 | 219 | |||
| A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients | Journal of magnetic resonance imaging | 2023 | 113 | 155 | |||
| Monocytosis in the acute phase of SARS-CoV-2 infection predicts the presence of anosognosia for cognitive deficits in the chronic phase | Brain, behavior, & immunity. Health | 2022 | 246 | 236 | |||
| Omicron-specific cytotoxic t-cell responses after a third dose of mrna covid-19 vaccine among patients with multiple sclerosis treated with ocrelizumab | JAMA neurology | 2022 | 250 | 186 | |||
| Prognostic biomarkers in primary progressive multiple sclerosis : Validating and scrutinizing multimodal evoked potentials | Clinical neurophysiology | 2022 | 41 | 171 | |||
| Long COVID neuropsychological deficits after severe, moderate or mild infection | Clinical and translational neuroscience | 2022 | 623 | 744 | |||
| Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis | JAMA neurology | 2022 | 244 | 442 | |||
| Robust T-Cell Responses in Anti-CD20 Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study | Clinical infectious diseases | 2022 | 236 | 163 | |||
| Functional connectivity underlying cognitive and psychiatric symptoms in post-COVID-19 syndrome: is anosognosia a key determinant? | Brain communications | 2022 | 424 | 345 | |||
| Answer to Letter to the Editor: High-resolution Black Blood Vessel Wall Imaging in COVID-19 Encephalopathy-is it Really Endotheliitis? | Clinical neuroradiology | 2022 | 185 | 53 | |||
| The Two-Way Route between Delirium Disorder and Dementia: Insights from COVID-19 | Neurodegenerative diseases | 2022 | 130 | 348 | |||
| CD4+c-Met+Itgα4+ T cell subset promotes murine neuroinflammation | Journal of neuroinflammation | 2022 | 238 | 126 | |||
| Intrathecal Synthesis Index of Specific Anti-Treponema IgG: a New Tool for the Diagnosis of Neurosyphilis | Microbiology spectrum | 2022 | 226 | 384 | |||
| Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDP | Neurology: Neuroimmunology & Neuroinflammation | 2021 | 919 | 466 | |||
| Rabies vaccination and multiple sclerosis relapse: A retrospective cohort study | Multiple Sclerosis and Related Disorders | 2021 | 352 | 197 | |||
| COVID‐19 encephalopathy: Clinical and neurobiological features | Journal of Medical Virology | 2021 | 353 | 452 | |||
| c-Met enforces proinflammatory and migratory features of human activated CD4+ T cells | Cellular & Molecular Immunology | 2021 | 339 | 235 | |||
| Live vaccines and immunosuppressive monoclonal antibodies: weighing up the benefit-risk assessment for natalizumab | Journal of Travel Medicine | 2021 | 237 | 1 | |||
| C-reactive protein and white matter microstructural changes in COVID-19 patients with encephalopathy | Journal of neural transmission | 2021 | 369 | 124 | |||
| Neuropathie des petites fibres dans les maladies autoimmunes systémiques | Revue médicale suisse | 2021 | 910 | 1 | |||
| Does Endothelial Vulnerability in OSA Syndrome Promote COVID-19 Encephalopathy? | Chest | 2021 | 184 | 98 | |||
| Cerebrovascular Complications and Vessel Wall Imaging in COVID-19 Encephalopathy—A Pilot Study | Clinical Neuroradiology | 2021 | 293 | 160 | |||
| Cerebrospinal Fluid Features in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reverse Transcription Polymerase Chain Reaction (RT-PCR) Positive Patients | Clinical infectious diseases | 2021 | 251 | 251 | |||
| Update in immunosuppressive therapy of myasthenia gravis | Autoimmunity reviews | 2021 | 50 | 425 | |||
| Encéphalopathie aiguë et Covid-19: hypothèses physiopathologiques | Revue médicale suisse | 2021 | 247 | 344 | |||
| Management of patients with generalised myasthenia gravis and COVID-19 : four case reports | Journal of neurology, neurosurgery and psychiatry | 2020 | 34 | 0 | |||
| Unusual Microbleeds in Brain MRI of Covid-19 Patients | Journal of Neuroimaging | 2020 | 876 | 508 | |||
| Risk of MS relapse after yellow fever vaccination: A self-controlled case series | Neurology: Neuroimmunology & Neuroinflammation | 2020 | 257 | 196 | |||
| SARS‐CoV‐2 and Guillain–Barré syndrome : AIDP variant with a favourable outcome | European journal of neurology | 2020 | 59 | 134 | |||
| c-Met is expressed by highly autoreactive encephalitogenic CD8+ cells | Journal of neuroinflammation | 2020 | 1 | 1 | |||
| COVID-19-related encephalopathy responsive to high-dose glucocorticoids | Neurology | 2020 | 228 | 1 | |||
| Serum neurofilament light chains in MS: Association with the Timed Up and Go | Neurology Neuroimmunology & Neuroinflammation | 2020 | 243 | 68 | |||
| IL-8 as a potential biomarker in Guillain-Barre Syndrome | European Cytokine Network | 2019 | 277 | 1 | |||
| Encephalitis and meningoencephalitis: chasing the culprit | Clinical Microbiology and Infection | 2019 | 308 | 168 | |||
| Pachymeningitis with optic neuropathy associated with extrapulmonary tuberculosis and secondary antiphospholipid syndrome | Multiple Sclerosis and Related Disorders | 2019 | 383 | 0 | |||
| AQP4 antibody-positive NMO spectrum disorder associated with Takayasu arteritis | Journal of the Neurological Sciences | 2019 | 303 | 1 | |||
| Diagnostic tools for immune causes of encephalitis | Clinical microbiology and infection | 2019 | 417 | 2 | |||
| Fulminant multifocal relapse in a fingolimod-treated multiple sclerosis patient | Multiple Sclerosis and Related Disorders | 2019 | 440 | 2 | |||
| In-vivo gp100-specific Cytotoxic CD8+ T Cell Killing Assay | Bio-protocol | 2018 | 330 | 600 | |||
| Syndrome de Guillain-Barré | Revue médicale suisse | 2018 | 697 | 860 | |||
| Activation of human B cells negatively regulates TGF-β1 production | Journal of Neuroinflammation | 2017 | 597 | 324 | |||
| Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients | Journal of Neuroinflammation | 2017 | 585 | 282 | |||
| Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis | Annals of Neurology | 2017 | 611 | 0 | |||
| Does fear of falling predict gait variability in multiple sclerosis? | Journal of the Neurological Sciences | 2017 | 640 | 0 | |||
| Gait stability in patients treated by fingolimod: A longitudinal pilot study on 9 patients with multiple sclerosis | Journal of the Neurological Sciences | 2017 | 684 | 3 | |||
| Gait Profile Score in multiple sclerosis patients with low disability | Gait & Posture | 2017 | 594 | 1 | |||
| Identification of a novel population of highly cytotoxic c-Met-expressing CD8(+) T lymphocytes | EMBO Reports | 2017 | 600 | 4 | |||
| Upper limb movement analysis during gait in multiple sclerosis patients | Human movement science | 2017 | 566 | 0 | |||
| [Paraneoplastic neurological syndromes: an update] | Revue médicale suisse | 2016 | 519 | 0 | |||
| Sclérose en plaques de forme primaire progressive : un traitement se révèle enfin efficace | Revue médicale suisse | 2016 | 612 | 8 | |||
| Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen | Acta neuropathologica | 2016 | 566 | 0 | |||
| Multiple sclerosis relapse mimicking a transient ischemic attack | Multiple sclerosis and related disorders | 2016 | 585 | 1 | |||
| Postural control is associated with cognition and fear of falling in patients with multiple sclerosis | Journal of neural transmission | 2016 | 528 | 0 | |||
| Gait variability in multiple sclerosis: a better falls predictor than EDSS in patients with low disability | Journal of neural transmission | 2016 | 666 | 1 | |||
| Stride time variability as a marker for higher level of gait control in multiple sclerosis: its association with fear of falling | Journal of neural transmission | 2016 | 587 | 0 | |||
| Anti-ApoA-1 IgG serum levels predict worse post-stroke outcomes | European journal of clinical investigation | 2016 | 635 | 6 | |||
| B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation | Scientific reports | 2016 | 629 | 315 | |||
| Meningoencephalitis with microinfarcts in early neuroborreliosis | Neuroradiology | 2016 | 562 | 1 | |||
| A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients | Multiple sclerosis | 2015 | 650 | 1 | |||
| Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MS | Neurology® neuroimmunology & neuroinflammation | 2015 | 486 | 0 | |||
| Minimal supportive treatment in natalizumab-related PML in a MS patient | Journal of neurology, neurosurgery and psychiatry | 2015 | 555 | 0 | |||
| A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - a twelve month follow-up | Journal of neuroimmunology | 2015 | 604 | 1 | |||
| Hepatocyte growth factor: A regulator of inflammation and autoimmunity | Autoimmunity reviews | 2015 | 566 | 0 | |||
| Hematologic modifications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal study | Neurology® neuroimmunology & neuroinflammation | 2015 | 492 | 389 | |||
| Transient gadolinium leakage in natalizumab-treated multiple sclerosis | Journal of neurology, neurosurgery and psychiatry | 2015 | 481 | 0 | |||
| Successful long-term ambulatory norepinephrine infusions in a patient with pure autonomic failure | Clinical autonomic research | 2015 | 538 | 0 | |||
| Cannabinoïdes médicaux dans les douleurs chroniques : aspects pharmacologiques | Revue médicale suisse | 2015 | 695 | 5 | |||
| Glatiramer acetate treatment negatively regulates type I interferon signaling | Neurology® neuroimmunology & neuroinflammation | 2015 | 477 | 1 | |||
| Multifocal motor neuropathy with high titers of anti-MAG antibodies | Journal of the peripheral nervous system | 2014 | 558 | 0 | |||
| Update on multiple sclerosis treatments | Schweizerische medizinische Wochenschrift | 2014 | 517 | 1 | |||
| Fingolimod in a patient with Wolff-Parkinson-White syndrome | Multiple sclerosis | 2014 | 449 | 0 | |||
| The neurotrophic hepatocyte growth factor induces protolerogenic human dendritic cells | Journal of neuroimmunology | 2014 | 553 | 0 | |||
| Hepatocyte growth factor limits autoimmune neuroinflammation via glucocorticoid-induced leucine zipper expression in dendritic cells | The Journal of immunology | 2014 | 698 | 3 | |||
| Dual-Task Assessment in Natalizumab-Treated Multiple Sclerosis Patients | European neurology | 2014 | 719 | 4 | |||
| 18FDG-PET-CT: an imaging biomarker of high-risk carotid plaques. Correlation to symptoms and microembolic signals | Stroke | 2014 | 717 | 3 | |||
| Walking while talking in patients with multiple sclerosis: the impact of specific cognitive loads | Neurophysiologie clinique | 2014 | 656 | 3 | |||
| Traitement de la sclérose en plaques : nouveautés et complications | Revue médicale suisse | 2013 | 496 | 0 | |||
| Cerebrospinal fluid interleukin-6 in central nervous system inflammatory diseases | PloS one | 2013 | 765 | 580 | |||
| Neuropathies associées aux paraprotéinémies (gammapathies monoclonales) | Revue médicale suisse | 2013 | 459 | 0 | |||
| Maladies auto-immunes neuromusculaires : diagnostic et prise en charge | Revue médicale suisse | 2013 | 477 | 0 | |||
| The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity | Journal of neuroinflammation | 2013 | 632 | 404 | |||
| Neuroborréliose, méningo-encéphalite verno-estivale et neurosyphilis | Revue médicale suisse | 2013 | 451 | 423 | |||
| Nogo-A downregulation improves insulin secretion in mice | Diabetes | 2013 | 709 | 344 | |||
| [Head inflammation] | Revue médicale suisse | 2013 | 411 | 0 | |||
| Adapted timed up and go: a rapid clinical test to assess gait and cognition in multiple sclerosis | European neurology | 2012 | 767 | 0 | |||
| IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis | Journal of neuroinflammation | 2012 | 728 | 357 | |||
| Interferon-β induces hepatocyte growth factor in monocytes of multiple sclerosis patients | PloS one | 2012 | 694 | 279 | |||
| Hypereosinophilia in patients with multiple sclerosis treated with natalizumab | Neurology | 2011 | 731 | 0 | |||
| Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis | Journal of neuroinflammation | 2011 | 655 | 353 | |||
| Antibody response in MOG35–55 induced EAE | Journal of neuroimmunology | 2011 | 769 | 884 | |||
| Encephalitis associated with glutamic acid decarboxylase autoantibodies in a child: a treatable condition? | Archives of neurology | 2011 | 712 | 0 | |||
| Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action | CNS drugs | 2011 | 608 | 0 | |||
| Highly reactive anti-myelin oligodendrocyte glycoprotein antibodies differentiate demyelinating diseases from viral encephalitis in children | Multiple sclerosis | 2011 | 594 | 0 | |||
| Biomarqueurs en neuroimmunologie | Revue médicale suisse | 2011 | 542 | 1 | |||
| Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune disease | PloS one | 2010 | 768 | 859 | |||
| VGKC antibody-associated encephalitis, microbleeds and progressive brain atrophy | Journal of neurology | 2010 | 708 | 353 | |||
| Glatiramer acetate triggers PI3Kdelta/Akt and MEK/ERK pathways to induce IL-1 receptor antagonist in human monocytes | Proceedings of the National Academy of Sciences of the United States of America | 2010 | 709 | 0 | |||
| Behaviorally spontaneous confabulation in limbic encephalitis: the roles of reality filtering and strategic monitoring | Journal of the International Neuropsychological Society | 2010 | 699 | 0 | |||
| MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity | The Journal of experimental medicine | 2010 | 703 | 1 | |||
| Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells | Proceedings of the National Academy of Sciences of the United States of America | 2010 | 726 | 0 | |||
| Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis | Proceedings of the National Academy of Sciences of the United States of America | 2009 | 647 | 0 | |||
| Peripheral autoimmune neuropathy assessed using corneal in vivo confocal microscopy | Archives of neurology | 2009 | 663 | 0 | |||
| Anomalous brain dominance and the immune system: do left-handers have specific immunological patterns? | Brain and cognition | 2009 | 696 | 0 | |||
| Increasing the diagnostic value of evoked potentials in multiple sclerosis by quantitative topographic analysis of multichannel recordings | Journal of clinical neurophysiology | 2009 | 713 | 2 | |||
| Autoanticorps en neurologie : implications cliniques | Revue médicale suisse | 2009 | 559 | 0 | |||
| Syndrome of transient headache and neurological deficits with CSF lymphocytosis (HaNDL) associated with recent human herpesvirus-6 infection | Cephalalgia | 2009 | 709 | 1 | |||
| Interferon-beta induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients | Journal of neuroimmunology | 2008 | 677 | 0 | |||
| Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model | International immunology | 2008 | 648 | 1 | |||
| Human herpesvirus-6 variant A encephalomyelitis | Neurology | 2008 | 676 | 0 | |||
| Autoantibodies in inflammatory demyelinating diseases of the central nervous system | Schweizerische medizinische Wochenschrift | 2008 | 608 | 4 | |||
| TNF-alpha and psychologically stressful events in healthy subjects: potential relevance for multiple sclerosis relapse | Behavioral neuroscience | 2002 | 524 | 0 | |||
| Encéphalopathie complexe, transitoire et récidivante après résection étendue de l'intestin grêle. Responsabilité du D-Lactate | Revue neurologique | 2001 | 598 | 0 | |||
| Lower limb corticobasal degeneration | European neurology | 2000 | 568 | 0 |
